Publications

Nature

cGAS-STING drives ageing-related inflammation and neurodegeneration.

01-08-2023

The Journal of pathology

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

01-08-2023

The Journal of pathology

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.

01-08-2023

Drug discovery today

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

01-08-2023

Clinical pharmacokinetics

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

01-08-2023

ESMO open

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.

01-08-2023

European journal of cancer (Oxford, England : 1990)

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

01-08-2023

JAMA network open

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer.

01-08-2023

The Lancet. Oncology

Common Sense Oncology: outcomes that matter.

01-08-2023

Clinical pharmacokinetics

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.

01-08-2023

Cancer medicine

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

01-08-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.

01-08-2023

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development.

01-08-2023

Die Pharmazie

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

01-08-2023

Patient education and counseling

Effects of a pre-visit online information tool about genetic counselling for ovarian cancer patients, a randomized controlled trial.

01-08-2023

Journal of cancer research and clinical oncology

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

31-07-2023

Journal of gastroenterology

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer.

31-07-2023

Acta oncologica (Stockholm, Sweden)

Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners.

28-07-2023

International journal of radiation oncology, biology, physics

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

28-07-2023

Investigative radiology

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

27-07-2023

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

24-07-2023

Nature communications

Obesity-associated changes in molecular biology of primary breast cancer.

21-07-2023

Insights into imaging

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

21-07-2023

Journal of patient-reported outcomes

Monitoring aerobic capacity in cancer survivors using self-reported questionnaires: criterion validity and responsiveness.

19-07-2023

Nature medicine

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

17-07-2023

Journal of medical genetics

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

14-07-2023

European radiology

Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.

14-07-2023

Journal of mammary gland biology and neoplasia

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research.

14-07-2023

The New England journal of medicine

Third-Line Therapy in Metastatic Colorectal Cancer.

13-07-2023

Thyroid research

Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study.

10-07-2023

Clinical cancer research : an official journal of the American Association for Cancer Research

Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer.

05-07-2023

International journal of molecular sciences

A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.

05-07-2023

Bioinformatics advances

snHiC: a complete and simplified snakemake pipeline for grouped Hi-C data analysis.

03-07-2023

Frontiers in immunology

Heterogeneity in functional genetic screens: friend or foe?

03-07-2023

Clinical pharmacokinetics

Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach.

01-07-2023

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society

Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.

01-07-2023

The Lancet. Oncology

Adjuvant immune checkpoint blockade revisited.

01-07-2023

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series.

01-07-2023

BJOG : an international journal of obstetrics and gynaecology

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.

01-07-2023

Journal of dental research

Microbial Indicators of Dental Health, Dysbiosis, and Early Childhood Caries.

01-07-2023

Biomedical chromatography : BMC

Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.

01-07-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Are hybrid conferences the new standard?

01-07-2023

European journal of nuclear medicine and molecular imaging

Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-^99mTc-nanocolloid vs. ICG-^99mTc-nanoscan from a nuclear medicine and surgical perspective.

01-07-2023

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Corrigendum to "Master protocol trial design for technical feasibility of MR-guided radiotherapy" [Radiother. Oncol. 166 (2022) 33-36].

01-07-2023

Molecular oncology

MND1 enables homologous recombination in somatic cells primarily outside the context of replication.

01-07-2023

Journal for immunotherapy of cancer

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.

01-07-2023

European journal of nuclear medicine and molecular imaging

A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.

01-07-2023

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients.

01-07-2023

Gynecologic oncology

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

01-07-2023

Nature

Heritable transcriptional defects from aberrations of nuclear architecture.

01-07-2023

cGAS-STING drives ageing-related inflammation and neurodegeneration.

Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group.

Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients.

Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors.

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma.

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer.

Common Sense Oncology: outcomes that matter.

Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.

Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development.

Development of a UPLC-MS/MS Assay for the Quantitative Determination of Capecitabine, 5'-deoxy-5-fluorocytidine (5'-dFCR), 5'-deoxy-5-fluorouridine (5'-dFUR), 5'-fluorouracil (5-FU), and α-fluoro-β-alanine (FBAL).

Effects of a pre-visit online information tool about genetic counselling for ovarian cancer patients, a randomized controlled trial.

Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer.

Involving adolescents and young adults (AYA) with an uncertain or poor cancer prognosis as research partners.

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction.

Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

Obesity-associated changes in molecular biology of primary breast cancer.

Radiomic signatures from T2W and DWI MRI are predictive of tumour hypoxia in colorectal liver metastases.

Monitoring aerobic capacity in cancer survivors using self-reported questionnaires: criterion validity and responsiveness.

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.

Development and multicenter validation of a multiparametric imaging model to predict treatment response in rectal cancer.

Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research.

Third-Line Therapy in Metastatic Colorectal Cancer.

Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study.

Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer.

A C57BL/6J Fancg-KO Mouse Model Generated by CRISPR/Cas9 Partially Captures the Human Phenotype.

snHiC: a complete and simplified snakemake pipeline for grouped Hi-C data analysis.

Heterogeneity in functional genetic screens: friend or foe?

Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach.

Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.

Adjuvant immune checkpoint blockade revisited.

Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series.

Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.

Microbial Indicators of Dental Health, Dysbiosis, and Early Childhood Caries.

Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.

Are hybrid conferences the new standard?

Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-99mTc-nanocolloid vs. ICG-99mTc-nanoscan from a nuclear medicine and surgical perspective.

Corrigendum to "Master protocol trial design for technical feasibility of MR-guided radiotherapy" [Radiother. Oncol. 166 (2022) 33-36].

MND1 enables homologous recombination in somatic cells primarily outside the context of replication.

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation.

A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients.

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.

Heritable transcriptional defects from aberrations of nuclear architecture.

This site uses cookies

Comparison of two hybrid sentinel node tracers: indocyanine green (ICG)-^99mTc-nanocolloid vs. ICG-^99mTc-nanoscan from a nuclear medicine and surgical perspective.